Publications by authors named "Mikhail Popkov"

Claim this Profile
M
Mental health in Central and Eastern Europe: a comprehensive analysis.
Petr Winkler, Zoe Guerrero, Anna Kågström, Michaela Petrášová, Arlinda Cerga Pashoja, Mikhail Popkov

Lancet Reg Health Eur· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment and long-term outcome of mental disorders: The grim picture from a quasi-epidemiological investigation in 54,826 subjects from 40 countries.
Konstantinos N Fountoulakis, Gregory Karakatsoulis, Seri Abraham, Kristina Adorjan, Helal Uddin Ahmed, Mikhail Popkov

Psychiatry Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-binary gender, vulnerable populations and mental health during the COVID-19 pandemic: Data from the COVID-19 MEntal health inTernational for the general population (COMET-G) study.
Konstantinos N Fountoulakis, Jelena Vrublevska, Seri Abraham, Kristina Adorjan, Helal Uddin Ahmed, Mikhail Popkov

J Affect Disord· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Somatic multicomorbidity and disability in patients with psychiatric disorders in comparison to the general population: a quasi-epidemiological investigation in 54,826 subjects from 40 countries (COMET-G study).
Konstantinos N Fountoulakis, Grigorios N Karakatsoulis, Seri Abraham, Kristina Adorjan, Helal Uddin Ahmed, Mikhail Popkov

CNS Spectr· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of the COVID-19 mental health international for the general population (COMET-G) study.
Konstantinos N Fountoulakis, Grigorios Karakatsoulis, Seri Abraham, Kristina Adorjan, Helal Uddin Ahmed, Mikhail Popkov

Eur Neuropsychopharmacol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Instant immunity through chemically programmable vaccination and covalent self-assembly.
Mikhail Popkov, Beatriz Gonzalez, Subhash C Sinha, Carlos F Barbas

Proc Natl Acad Sci U S A· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small molecule drug activity in melanoma models may be dramatically enhanced with an antibody effector.
Mikhail Popkov, Christoph Rader, Beatriz Gonzalez, Subhash C Sinha, Carlos F Barbas

Int J Cancer· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zinc finger transcription factors designed for bispecific coregulation of ErbB2 and ErbB3 receptors: insights into ErbB receptor biology.
Caren V Lund, Mikhail Popkov, Laurent Magnenat, Carlos F Barbas

Mol Cell Biol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prodrug activation gated by a molecular "OR" logic trigger.
Roey J Amir, Mikhail Popkov, Richard A Lerner, Carlos F Barbas, Doron Shabat

Angew Chem Int Ed Engl· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypic knockout of VEGF-R2 and Tie-2 with an intradiabody reduces tumor growth and angiogenesis in vivo.
Nina Jendreyko, Mikhail Popkov, Christoph Rader, Carlos F Barbas

Proc Natl Acad Sci U S A· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring strategies for the design of artificial transcription factors: targeting sites proximal to known regulatory regions for the induction of gamma-globin expression and the treatment of sickle cell disease.
Torbjörn Gräslund, Xuelin Li, Laurent Magnenat, Mikhail Popkov, Carlos F Barbas

J Biol Chem· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting tumor angiogenesis with adenovirus-delivered anti-Tie-2 intrabody.
Mikhail Popkov, Nina Jendreyko, Dorian B McGavern, Christoph Rader, Carlos F Barbas

Cancer Res· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-triggered trimeric prodrugs.
Keren Haba, Mikhail Popkov, Marina Shamis, Richard A Lerner, Carlos F Barbas

Angew Chem Int Ed Engl· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolation of human prostate cancer cell reactive antibodies using phage display technology.
Mikhail Popkov, Christoph Rader, Carlos F Barbas

J Immunol Methods· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Promoter-targeted phage display selections with preassembled synthetic zinc finger libraries for endogenous gene regulation.
Caren V Lund, Pilar Blancafort, Mikhail Popkov, Carlos F Barbas

J Mol Biol· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human/mouse cross-reactive anti-VEGF receptor 2 recombinant antibodies selected from an immune b9 allotype rabbit antibody library.
Mikhail Popkov, Nina Jendreyko, Gualberto Gonzalez-Sapienza, Rose G Mage, Christoph Rader

J Immunol Methods· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrin alphaIIbbeta3-specific synthetic human monoclonal antibodies and HCDR3 peptides that potently inhibit platelet aggregation.
Junho Chung, Christoph Rader, Mikhail Popkov, Young-Mi Hur, Hyun-Kyung Kim

FASEB J· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intradiabodies, bispecific, tetravalent antibodies for the simultaneous functional knockout of two cell surface receptors.
Nina Jendreyko, Mikhail Popkov, Roger R Beerli, Junho Chung, Dorian B McGavern

J Biol Chem· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemically programmed monoclonal antibodies for cancer therapy: adaptor immunotherapy based on a covalent antibody catalyst.
Christoph Rader, Subhash C Sinha, Mikhail Popkov, Richard A Lerner, Carlos F Barbas

Proc Natl Acad Sci U S A· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid monoclonal antibody generation via dendritic cell targeting in vivo.
Jody D Berry, Alexei Licea, Mikhail Popkov, Xochitl Cortez, Roberta Fuller

Hybrid Hybridomics· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rabbit immune repertoires as sources for therapeutic monoclonal antibodies: the impact of kappa allotype-correlated variation in cysteine content on antibody libraries selected by phage display.
Mikhail Popkov, Rose G Mage, Cornelius B Alexander, Sujatha Thundivalappil, Carlos F Barbas

J Mol Biol· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrin alpha(v)beta3 targeted therapy for Kaposi's sarcoma with an in vitro evolved antibody.
Christoph Rader, Mikhail Popkov, John A Neves, Carlos F Barbas

FASEB J· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis